Wild-type (senile) amyloidosis echocardiography and ultrasound: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 20: Line 20:
  | pmid = 29707360
  | pmid = 29707360
}}</ref>
}}</ref>
 
*Other echocardiographic findings related to cardiac amyloidosis include:
:*Diastolic dysfunction with preserved ejection fraction (hallmark)<ref>{{Cite journal
| author = [[Wendy Tsang]] & [[Roberto M. Lang]]
| title = Echocardiographic evaluation of cardiac amyloid
| journal = [[Current cardiology reports]]
| volume = 12
| issue = 3
| pages = 272–276
| year = 2010
| month = May
| doi = 10.1007/s11886-010-0108-7
| pmid = 20424972
}}</ref><ref>{{Cite journal
| author = [[Diego Bellavia]], [[Patricia A. Pellikka]], [[Theodore P. Abraham]], [[Ghormallah B. Al-Zahrani]], [[Angela Dispenzieri]], [[Jae K. Oh]], [[Kent R. Bailey]], [[Christina M. Wood]], [[Martha Q. Lacy]], [[Chinami Miyazaki]] & [[Fletcher A. Jr Miller]]
| title = Evidence of impaired left ventricular systolic function by Doppler myocardial imaging in patients with systemic amyloidosis and no evidence of cardiac involvement by standard two-dimensional and Doppler echocardiography
| journal = [[The American journal of cardiology]]
| volume = 101
| issue = 7
| pages = 1039–1045
| year = 2008
| month = April
| doi = 10.1016/j.amjcard.2007.11.047
| pmid = 18359328
}}</ref>
:*
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 14:51, 19 December 2019

Wild-type (senile) amyloidosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Wild-type (senile) amyloidosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Wild-type (senile) amyloidosis echocardiography and ultrasound On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Wild-type (senile) amyloidosis echocardiography and ultrasound

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Wild-type (senile) amyloidosis echocardiography and ultrasound

CDC on Wild-type (senile) amyloidosis echocardiography and ultrasound

Wild-type (senile) amyloidosis echocardiography and ultrasound in the news

Blogs on Wild-type (senile) amyloidosis echocardiography and ultrasound

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Wild-type (senile) amyloidosis echocardiography and ultrasound

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2]

Overview

Echocardiography/Ultrasound

Echocardiography

  • Echocardiography is the most frequently used diagnostic modality for cardiomyopathy.
  • The most commonly encountered pathology on 2D echocardiography is increased left ventricular thickness (secondary to amyloid fibrils deposition in the extracellular matrix).[1]
  • Other echocardiographic findings related to cardiac amyloidosis include:
  • Diastolic dysfunction with preserved ejection fraction (hallmark)[2][3]

References

  1. Ilia G. Halatchev, Jingsheng Zheng & Jiafu Ou (2018). "Wild-type transthyretin cardiac amyloidosis (ATTRwt-CA), previously known as senile cardiac amyloidosis: clinical presentation, diagnosis, management and emerging therapies". Journal of thoracic disease. 10 (3): 2034–2045. doi:10.21037/jtd.2018.03.134. PMID 29707360. Unknown parameter |month= ignored (help)
  2. Wendy Tsang & Roberto M. Lang (2010). "Echocardiographic evaluation of cardiac amyloid". Current cardiology reports. 12 (3): 272–276. doi:10.1007/s11886-010-0108-7. PMID 20424972. Unknown parameter |month= ignored (help)
  3. Diego Bellavia, Patricia A. Pellikka, Theodore P. Abraham, Ghormallah B. Al-Zahrani, Angela Dispenzieri, Jae K. Oh, Kent R. Bailey, Christina M. Wood, Martha Q. Lacy, Chinami Miyazaki & Fletcher A. Jr Miller (2008). "Evidence of impaired left ventricular systolic function by Doppler myocardial imaging in patients with systemic amyloidosis and no evidence of cardiac involvement by standard two-dimensional and Doppler echocardiography". The American journal of cardiology. 101 (7): 1039–1045. doi:10.1016/j.amjcard.2007.11.047. PMID 18359328. Unknown parameter |month= ignored (help)